Skip to content

Menu

Guarding the Lifeline of Dialysis Patients

Home
Team
Technology
News
Contact

Close Menu

Soli D

About Soli D

Posts by Soli D:

February 15, 2024

PatenSee and Fresenius Medical Care Sign Clinical Collaboration Agreement

Soli D Press Release

Home
Team
Technology
News
Contact

© Patensee 2024

Powered by: SPInc

PatenSee is an emerging, clinical-stage, startup company with a novel, contactless imaging device for the early detection of vascular access complications in hemodialysis patients. The technology uses a unique data stream to mimic a best practice, physical examination. PatenSee recently signed a clinical collaboration agreement with Fresenius Medical Care, following the completion of a POC clinical trial with very promising results.

PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.